Health Industry Watch
SEE OTHER BRANDS

Your healthcare and wellness news reporter

Health Industry Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.

Press releases published on March 19, 2025

Healthcare Integrated Technologies Inc. Announces First School Partnership for SafeSpace AI Platform - SafeSchool

Healthcare Integrated Technologies Inc. Announces First School Partnership for SafeSpace AI Platform - SafeSchool

Brentwood Academy in Nashville, TN will Launch Advanced Safety Measures Knoxville, TN, March 19, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies Inc. (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, is proud to …

Revive Therapeutics Announces Results of Annual Shareholder Meeting

Revive Therapeutics Announces Results of Annual Shareholder Meeting

TORONTO, March 19, 2025 (GLOBE NEWSWIRE) --  Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases, …

Capsa Healthcare Unveils Cutting-Edge Innovation Center, Elevating Collaborative Healthcare Solutions

Capsa Healthcare Unveils Cutting-Edge Innovation Center, Elevating Collaborative Healthcare Solutions

COLUMBUS, Ohio, March 19, 2025 (GLOBE NEWSWIRE) -- Capsa Healthcare, a pioneer in medication management, pharmacy automation, and point-of-care technologies, proudly announces the grand opening of its state-of-the-art Innovation Center at its corporate …

Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

Proscia Raises $50M To Advance AI-Driven Pathology And Deliver The Future Of Precision Medicine

Proscia is rewiring pathology to speed up the development of targeted therapies, accelerate diagnosis, and match more patients with the best course of treatment Funding led by global software investor Insight Partners comes as the surge in cancer cases …

Jushi Holdings Inc. Announces Ohio Retail Updates Including the Opening of Beyond Hello™ Warren, Expanding Its Presence in Ohio’s Emerging Adult-Use Market

Jushi Holdings Inc. Announces Ohio Retail Updates Including the Opening of Beyond Hello™ Warren, Expanding Its Presence in Ohio’s Emerging Adult-Use Market

New Beyond Hello™ Adult-Use and Medical Dispensary Opens in Warren, OH Strengthening Jushi’s Ohio Retail Presence with Fourth Dispensary in the State Grand Opening Celebration with Exclusive Promotions on March 20, 2025 BOCA RATON, Fla., March 19, 2025 ( …

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

First-of-its-Kind Multicenter Study Demonstrates Utility of Monopoint System in Procedures to Treat Idiopathic Intracranial Hypertension

Monopoint system enables rapid access to the venous system Research to be presented at SNIS Cerebral Venous and CSF Disorders Summit SAN MATEO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical technology company …

Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson

Can-Fite to Initiate Phase II Study in the Rare Genetic Disease Lowe Syndrome with Piclidenoson

FDA …

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

NEXGEL to Report Fourth Quarter and Full Year 2024 Financial Results on March 24th

Management will host a conference call at 4:30 p.m. ET on the same day LANGHORNE, Pa., March 19, 2025 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products …

Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein

Sonnet BioTherapeutics Receives Notice of Allowance for U.S. Patent Covering Composition of Matter of Specific Amino Acid Substitutions of its IL-18 Binding Protein Resistant Variant Protein

Company advancing development of its modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhibits wild-type binding to the IL-18 receptor (IL-18Rc), coupled with undetectable binding to the inhibitory IL-18 Binding Protein …

SpinSci Technologies Expands Leadership Team to Drive Growth and Customer Excellence

SpinSci Technologies Expands Leadership Team to Drive Growth and Customer Excellence

SpinSci's New Leadership Appointments Position SpinSci Technologies for Scalable Growth, Enhanced Customer Support, and Operational Excellence DALLAS, TX, UNITED STATES, March 18, 2025 /⁨EINPresswire.com⁩/ -- SpinSci Technologies, a leading provider of …

Lipozem Reviews (Is It Safe And Legit To Use?) Ingredients, Side Effect Complaints, And Weight Loss Benefits!

Lipozem Reviews (Is It Safe And Legit To Use?) Ingredients, Side Effect Complaints, And Weight Loss Benefits!

LAKELAND, Fla., March 19, 2025 (GLOBE NEWSWIRE) -- Lipozem is a weight loss supplement crafted to support burning fat without causing adverse or side effects. It contains carefully selected ingredients that activate thermogenesis and amplify metabolism. It …

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 19 MARCH 2025 at 14.30 EET                        Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has …

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

ORION OYJ         PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE         19.3.2025 KLO 14.30          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session

Tenaya Therapeutics Announces Late Breaker and New Data Presentations at the American College of Cardiology’s Annual Scientific Session

SOUTH SAN FRANCISCO, Calif., March 19, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying …

Lirum Therapeutics Invited to Present at Prestigious Gordon Research Conference

Lirum Therapeutics Invited to Present at Prestigious Gordon Research Conference

New York, NY, March 19, 2025 (GLOBE NEWSWIRE) -- Lirum Therapeutics, Inc. (“Lirum”), an innovative clinical-stage biopharmaceutical company focused on the treatment of debilitating diseases, announced today that the Company has been invited to present at …

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, formulation optimization, and IP expansion, positioning the Company for near-term milestones and growth. NAPLES, …

Progressive Reports February 2025 Results

Progressive Reports February 2025 Results

MAYFIELD VILLAGE, OHIO, March 19, 2025 (GLOBE NEWSWIRE) -- The Progressive Corporation (NYSE:PGR) today reported the following results for the month ended February 28, 2025:   February (millions, except per share amounts and ratios; unaudited) 2025   2024 …

Theriva™ Biologics to Present at the 2025 NeauxCancer Conference

Theriva™ Biologics to Present at the 2025 NeauxCancer Conference

ROCKVILLE, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that the …

FDA Clears Magstim Transcranial Magnetic Stimulation System for U.S. Adolescent Patient Treatment

FDA Clears Magstim Transcranial Magnetic Stimulation System for U.S. Adolescent Patient Treatment

MINNEAPOLIS, March 19, 2025 (GLOBE NEWSWIRE) -- Major depression impacts more than 5 million U.S. adolescents every year, and NIH data shows that 20% of those aged 12 to 16 have had at least one major depressive episode*. The FDA has now cleared the …

FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.

FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.

MINNEAPOLIS, MN, March 19, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information and biospecimen …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service